October 23rd, 2024
We are proud to announce that #Surge, supported by #LallianSe since late 2021, made the cover of #NatureBiotechnology this month with their groundbreaking paper, “Discovery of sparse and reliable omics biomarkers with Stabl”.
📖 You can read the full article in open access here: https://lnkd.in/eEACUhxh
April 2, 2024
🚀 We are delighted to announce that #Surge, supported by #LallianSe since the end of 2021 has just conpleted its second fundraising of €7.5M ! 🚀
For more than two years we have worked closely alongside #Surge leaders on the issues of #fundraising and execution of an attractive and coherent #equitystory as a #SparringPartner. But what is a “Sparring Partner”?
He is above all a #partner. With a tailor-made approach and in a relationship of equals, we support, manage, question, strengthen and explore strategies and their implementation together.
We face challenges together, and celebrate victories together. Congratulations to the whole #Team: Julien Hedou, Valentin Picot, Brice Gaudilliere, Dyani Jones, Franck Verdonk, Benjamin Choisy, Grégoire Bellan.
#finance #investment #startup #innovation #PrecisionMedicine
22 septembre 2022
🚀 We are delighted to announce that SurgeCare has just completed its first fundraising of €2.5M and concluded an exclusive licensing agreement with Stanford!
For 9 months LallianSe has been working alongside Surge managers as a “Sparring Partner” on fundraising/equity story issues. “Sparring Partner”: what is it?
➡️Tailored support for the management team in its strategic orientations
➡️Support also in the management, coordination and animation of governance
➡️Access to our network of Experts and Entrepreneurs in residence
Congratulations to the whole #Team: Julien Hédou, Brice Gaudilliere, Dyani Jones, Franck Verdonk, Benjamin Choisy, Grégoire Bellan, Valentin Picot !
#equitystory #sparringpartner #privateequity #financement#investment